Bank of Montreal’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $536K | Sell |
38,727
-1,533
| -4% | -$21.3K | ﹤0.01% | 2359 |
|
|
2025
Q4 | $565K | Buy |
40,260
+28,742
| +250% | +$403K | ﹤0.01% | 2249 |
|
|
2025
Q3 | $161K | Buy |
+11,518
| New | +$166K | ﹤0.01% | 2839 |
|
|
2024
Q3 | – | Sell |
-49,590
| Closed | -$758K | – | 4175 |
|
|
2024
Q2 | $758K | Buy |
49,590
+21,310
| +75% | +$305K | ﹤0.01% | 2183 |
|
|
2024
Q1 | $416K | Buy |
+28,280
| New | +$413K | ﹤0.01% | 2568 |
|
|
2022
Q4 | – | Sell |
-74,105
| Closed | -$786 | – | 4232 |
|
|
2022
Q3 | $786 | Sell |
74,105
-3,565
| -5% | -$38K | ﹤0.01% | 2321 |
|
|
2022
Q2 | $868 | Sell |
77,670
-19,270
| -20% | -$210K | ﹤0.01% | 2400 |
|
|
2022
Q1 | $1.1M | Sell |
96,940
-66,255
| -41% | -$751K | ﹤0.01% | 2261 |
|
|
2021
Q4 | $2.14M | Sell |
163,195
-3,306,395
| -95% | -$41.7M | ﹤0.01% | 1561 |
|
|
2021
Q3 | $45.4M | Sell |
3,469,590
-2,185
| -0.1% | -$29.1K | 0.02% | 588 |
|
|
2021
Q2 | $51.1M | Sell |
3,471,775
-223,380
| -6% | -$3.12M | 0.03% | 504 |
|
|
2021
Q1 | $46.4M | Buy |
3,695,155
+924,075
| +33% | +$11.9M | 0.03% | 423 |
|
|
2020
Q4 | $40.5M | Buy |
2,771,080
+671,920
| +32% | +$9.05M | 0.03% | 480 |
|
|
2020
Q3 | $29M | Buy |
2,099,160
+915,380
| +77% | +$10.9M | 0.02% | 477 |
|
|
2020
Q2 | $12.3M | Buy |
1,183,780
+818,580
| +224% | +$8.33M | 0.01% | 744 |
|
|
2020
Q1 | $2.96M | Sell |
365,200
-474,240
| -56% | -$3.95M | ﹤0.01% | 1239 |
|
|
2019
Q4 | $6.81M | Buy |
839,440
+26,590
| +3% | +$210K | 0.01% | 1188 |
|
|
2019
Q3 | $6.16M | Buy |
812,850
+120,490
| +17% | +$896K | 0.01% | 1088 |
|
|
2019
Q2 | $5.19M | Buy |
692,360
+189,890
| +38% | +$1.49M | ﹤0.01% | 1184 |
|
|
2019
Q1 | $4.07M | Sell |
502,470
-108,700
| -18% | -$826K | ﹤0.01% | 1280 |
|
|
2018
Q4 | $4.61M | Sell |
611,170
-124,770
| -17% | -$878K | ﹤0.01% | 1106 |
|
|
2018
Q3 | $5.09M | Buy |
735,940
+38,600
| +6% | +$258K | ﹤0.01% | 1175 |
|
|
2018
Q2 | $4.49M | Sell |
697,340
-109,085
| -14% | -$688K | ﹤0.01% | 1222 |
|
|
2018
Q1 | $5.27M | Buy |
806,425
+85,095
| +12% | +$596K | ﹤0.01% | 1122 |
|
|
2017
Q4 | $5.42M | Sell |
721,330
-44,805
| -6% | -$323K | ﹤0.01% | 1108 |
|
|
2017
Q3 | $5.47M | Buy |
766,135
+232,265
| +44% | +$1.67M | 0.01% | 1127 |
|
|
2017
Q2 | $4.5M | Buy |
533,870
+151,650
| +40% | +$1.23M | ﹤0.01% | 1204 |
|
|
2017
Q1 | $3.07M | Sell |
382,220
-25,050
| -6% | -$216K | ﹤0.01% | 1297 |
|
|
2016
Q4 | $3.81M | Buy |
407,270
+3,805
| +0.9% | +$35.4K | ﹤0.01% | 1197 |
|
|
2016
Q3 | $3.75M | Sell |
403,465
-29,195
| -7% | -$279K | ﹤0.01% | 1224 |
|
|
2016
Q2 | $4.43M | Sell |
432,660
-26,640
| -6% | -$244K | 0.01% | 1144 |
|
|
2016
Q1 | $4.15M | Buy |
459,300
+35,675
| +8% | +$319K | ﹤0.01% | 1107 |
|
|
2015
Q4 | $3.92M | Sell |
423,625
-55,920
| -12% | -$612K | ﹤0.01% | 1089 |
|
|
2015
Q3 | $6.13M | Sell |
479,545
-36,475
| -7% | -$453K | 0.01% | 902 |
|
|
2015
Q2 | $5.71M | Buy |
516,020
+133,410
| +35% | +$1.47M | 0.01% | 1023 |
|
|
2015
Q1 | $4.37M | Buy |
382,610
+14,555
| +4% | +$154K | 0.01% | 1088 |
|
|
2014
Q4 | $3.71M | Sell |
368,055
-139,395
| -27% | -$1.47M | ﹤0.01% | 1148 |
|
|
2014
Q3 | $5.33M | Buy |
507,450
+66,640
| +15% | +$626K | 0.01% | 1057 |
|
|
2014
Q2 | $3.8M | Buy |
440,810
+11,610
| +3% | +$97.6K | ﹤0.01% | 1194 |
|
|
2014
Q1 | $3.77M | Buy |
429,200
+36,485
| +9% | +$317K | ﹤0.01% | 1047 |
|
|
2013
Q4 | $3.22M | Buy |
392,715
+195,200
| +99% | +$1.55M | ﹤0.01% | 989 |
|
|
2013
Q3 | $1.49M | Buy |
197,515
+100,525
| +104% | +$731K | ﹤0.01% | 1276 |
|
|
2013
Q2 | $734K | Buy |
+96,990
| New | +$708K | ﹤0.01% | 1540 |
|
Other funds holding RDY
AIM
Bank of Montreal's RDY Position: Q1 2026 in Review
Bank of Montreal reduced its Dr. Reddy's Laboratories (RDY) stake by 3.8% in Q1 2026, selling an estimated $21.3K and leaving 38,727 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #2359.
Bank of Montreal first reported a position in RDY in Q2 2013 and has held it in 43 quarters since. The position peaked at $51.1M in Q2 2021. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.
- Bank of Montreal held 38,727 shares of Dr. Reddy's Laboratories worth $536K as of Q1 2026.
- Bank of Montreal sold 1,533 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $21.3K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2359 holding.
- Bank of Montreal first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 43 quarters since.
- Bank of Montreal's Dr. Reddy's Laboratories position peaked at $51.1M in Q2 2021.
- 248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.